ArticleExperimental and therapeutic medicine2018

Resolvin D1 inhibits the proliferation of lipopolysaccharide-treated HepG2 hepatoblastoma and PLC/PRF/5 hepatocellular carcinoma cells by targeting the MAPK pathway.

You Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.